Catalyst Wire Dossier Catalyst Wire Dossier

Mysimba

naltrexone/bupropion
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Mysimba, covering 2014-12-19 to 2026-04-10. Get the full timeline:

Most recent: EMA Authorised: Mysimba (bupropion hydrochloride;naltrexone hydrochloride) — Orexigen Therapeutics Ireland Limited

See pricing